CompletedNCT01284517
Official study titleA Randomized, 6-week Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression in Subjects Demonstrating Non-response to Treatment With Lithium or Divalproex Alone.
This study has finished and is no longer accepting participants.
Multiple locations, including Costa MesaBipolarity, DepressionMedication studyAges 18–75
- Countries
- United States, Canada, Colombia, + 7 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT02046369
What is this study about?Researchers compared Lurasidone and placebo, tracking side effects to assess safety in children with bipolarity type I during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanBipolarity, DepressionMedication studyAges 10–17
- Countries
- United States, France, Bulgaria, + 7 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT00382915
Official study titleNicotine Intake in Smokers With Schizophrenia
This study has finished and is no longer accepting participants.
In New BrunswickBipolarity, SchizophreniaObservational studyAges 18–75
- Countries
- United States
- Sponsor
- University of Medicine and Dentistry of New Jersey
CompletedNCT03630822
Official study titleExperimentation of a Protocol of Psychiatric Advance Directives: Randomized Controlled Multi-site Trial
This study has finished and is no longer accepting participants.
In MarseilleBipolarity, SchizophreniaBehavioural studyAges 18+
- Countries
- France
- Sponsor
- Assistance Publique Hopitaux De Marseille
CompletedNCT01929681
Official study titleLow Field Magnetic Stimulation in Mood Disorders: Three Daily Visits
This study has finished and is no longer accepting participants.
In BelmontBipolarity, DepressionDevice studyAges 21–65
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
CompletedNCT03402152
Official study titleValidation of the Glx Biomarker for Treatment of Moderate Bipolar Depression With NRX-101
This study has finished and is no longer accepting participants.
In New YorkSuicidality, Bipolarity, ...Medication studyAges 18–65
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
CompletedNCT02287259
Official study titleA Randomized, Open Label Trial of Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified.
This study has finished and is no longer accepting participants.
In ChibaBipolarity, DepressionMedication studyAges 18–65
- Countries
- Japan
- Sponsor
- Tadashi Hasegawa
CompletedNCT00485771
Official study titleOlanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression
This study has finished and is no longer accepting participants.
In LafayetteBipolarity, DepressionMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Eli Lilly and Company
WithdrawnNCT00204503
Official study titleAn Open Label Pilot Study Evaluating Safety and Efficacy of Divalproex Sodium (Depakote ER) in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence.
This study was withdrawn before enrollment.
In GalvestonBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- The University of Texas Medical Branch, Galveston
CompletedNCT00237666
What is this study about?Researchers studied Ziprasidone to find out how it affected depression symptoms in people with bipolarity type II during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including New YorkBipolarity, DepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- The Medical Research Network
CompletedNCT06053346
Official study titleEvaluation of the Santa Clara County Mental Health Service Pay for Performance Quality Improvement Initiative
This study has finished and is no longer accepting participants.
Location not clearly listedAddiction, Bipolarity, ...Behavioural studyAges 18–65
- Countries
- Sponsor
- Stanford University
CompletedNCT00422123
Official study titleA Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Mania
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixBipolarity, Schizophrenia, ...Medication studyAges 18–65
- Countries
- United States
- Sponsor
- AstraZeneca
